Hana Yoon

Hana Yoon

Auto-generated profile, based on publicly available information

Hana Yoon

Department of Urology, Ewha Womans University College of Medicine, Seoul, Korea

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2006 in International Journal Of Impotence Research
Verified
Journal Article
Closed access
HYH Yoon
H Yoon
WCW S Chung
W S Chung
BSB S Shim
B S Shim

28 October 2004 in International Journal Of Impotence Research
Verified
Journal Article
Closed access
YKY H Kim
Y H Kim
JSJ T Seo
J T Seo
HYH Yoon
H Yoon

18 April 2020 in Diagnostics
Verified
Journal Article
Open access
PDF file
ELEun Young Lee
Eun Young Lee
ELEun-Ju Lee
Eun-Ju Lee
HYHana Yoon
Hana Yoon
DLDong Hyeon Lee
Dong Hyeon Lee
KKKwang Hyun Kim
Kwang Hyun Kim
Urinary cell-free DNA (cfDNA) is an attractive body fluid for liquid biopsy. In this study, we compared the efficiencies of four commercial kits for urinary cell-free DNA (cfDNA) isolation and of various sample storage conditions. Urinary cfDNA was isolated from 10 healthy individuals using four commercial kits: QIAamp Circulating Nucleic Acid Kit (QC; Qiagen), MagMAX™ Cell-Free DNA Isolation Kit (MM; Applied Biosystems), Urine Cell-Free Circulating DNA Purification Midi Kit (NU; Norgen Biotek), and Quick-DNA™ Urine Kit (ZQ; Zymo Research). To assess the isolation efficiency, an Agilent 2100 Bioanalyzer with High Sensitivity DNA chips was used, and cfDNA yield was defined as the amount of cfDNA obtained from 1 mL of urine. MM and QC provided the highest cfDNA yield in the 50–300 bp range, and MM and NU gave the highest cfDNA yield in the 50–100 bp range. In particular, the NU kit was efficient for isolation of more fragmented cfDNA in the range of 50–100 bp with the lowest cellular genomic DNA contamination. ZQ had the best cost-efficiency for isolating the same amount of urinary cfDNA. Samples stored at −70 °C with the addition of 10 mM EDTA resulted in the highest cfDNA yield 3 months after sample collection.

1 January 2010 in Korean Journal of Urology
Verified
Journal Article
Open access
PDF file
GHGeun Sik Hong
Geun Sik Hong
BSBong Suk Shim
Bong Suk Shim
WCWoo Sik Chung
Woo Sik Chung
HYHana Yoon
Hana Yoon
Hong GS, et al. Korean J Urol. 2010 Sep;51(9):631-635. http://dx.doi.org/10.4111/kju.2010.51.9.631

1 March 2024 in Science Immunology
Verified
Journal Article
Closed access
BHByron W. Hayes
Byron W. Hayes
Hae Woong ChoiHae Woong Choi
Hae Woong Choi
ARAbhay P.S. Rathore
Abhay P.S. Rathore
CBChunjing Bao
Chunjing Bao
JSJianling Shi
Jianling Shi
Soman AbrahamSoman Abraham
Soman Abraham
Urinary tract infections (UTIs) account for almost 25% of infections in women. Many are recurrent (rUTI), with patients frequently experiencing chronic pelvic pain and urinary frequency despite clearance of bacteriuria after antibiotics. To elucidate the basis for these bacteria-independent bladder symptoms, we examined the bladders of patients with rUTI. We noticed a notable increase in neuropeptide content in the lamina propria and indications of enhanced nociceptive activity. In mice subjected to rUTI, we observed sensory nerve sprouting that was associated with nerve growth factor (NGF) produced by recruited monocytes and tissue-resident mast cells. Treatment of rUTI mice with an NGF-neutralizing antibody prevented sprouting and alleviated pelvic sensitivity, whereas instillation of native NGF into naïve mice bladders mimicked nerve sprouting and pain behavior. Nerve activation, pain, and urinary frequency were each linked to the presence of proximal mast cells, because mast cell deficiency or treatment with antagonists against receptors of several direct or indirect mast cell products was each effective therapeutically. Thus, our findings suggest that NGF-driven sensory sprouting in the bladder coupled with chronic mast cell activation represents an underlying mechanism driving bacteria-independent pain and voiding defects experienced by patients with rUTI.

1 January 2016 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
KKKwang Hyun Kim
Kwang Hyun Kim
HYHyun Suk Yoon
Hyun Suk Yoon
HYHana Yoon
Hana Yoon
WCWoo Sik Chung
Woo Sik Chung
BSBong Suk Sim
Bong Suk Sim
DLDong Hyeon Lee
Dong Hyeon Lee
Kim KH, et al. J Korean Med Sci. 2016 Jul;31(7):1100-1104. http://dx.doi.org/10.3346/jkms.2016.31.7.1100